CIK 0001253689 · Non-accelerated filer<br>Smaller reporting company
CRESCENT BIOPHARMA, INC.
Sign in to watch- Ticker
- CBIO
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- Cayman Islands
- Entity type
- operating
- Phone
- 617-430-5595
- Business address
- 300 FIFTH AVENUE, WALTHAM, MA, 02451
- Former names
- GLYCOMIMETICS INC
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- SCHEDULE 13D/A Stake Beneficial Ownership Report
- 4 Open-market buy Director bought 853,450 shares at $14.50 ($12,375,025)
- 8-K Event Other events
- 424B5 Offering Prospectus
- 8-K Event Results of operations
- 424B5 Offering Prospectus
- EFFECT Other Notice of Effectiveness
- S-3 Offering Registration Statement
- 4 Planned sale See Remarks sold 465 shares at $17.99 ($8,365)
- 4 Planned sale Chief Scientific Officer sold 1,288 shares at $17.99 ($23,171)
- 4 Planned sale Chief Financial Officer sold 1,112 shares at $17.99 ($20,005)
- 4 Planned sale See Remarks sold 1,218 shares at $17.99 ($21,912)
- 4 Planned sale Chief Medical Officer sold 1,219 shares at $17.99 ($21,930)
- 4 Planned sale President and COO sold 20,549 shares at $17.99 ($369,677)
- 4 Planned sale Chief Executive Officer sold 42,305 shares at $17.99 ($761,067)
- 424B3 Offering Prospectus
- 10-Q/A Report 10-Q/A
- 4 Derivatives Options or other derivatives
Page 2 of 34 · 678 filings